Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

FDA advisory committee meeting scheduled to review Enbrel BLA

Aug. 25, 1998

Mitsui Toatsu researches cell adhesion inhibitors for a range of potential indications

Aug. 21, 1998

Immune Response evaluates rheumatoid arthritis vaccine in follow-up trial

Aug. 21, 1998

Antiarthritic activity of cromoglicate lisetil in a model of immunologically-mediated disease

Aug. 20, 1998

Kotobuki also conducting research on COX-2 inhibitors

Aug. 19, 1998

New COX-2 inhibitors in early development at American Home

Aug. 18, 1998

Chiral aspects of the pharmacokinetics of flobufen: important implications for therapeutic use

Aug. 14, 1998

NSAID from Sigma-Tau is devoid of GI side effects

Aug. 13, 1998

Pfizer investigates COX-2 inhibitors as potential antiinflammatory agents

Aug. 13, 1998

Hoechst discovers modulators of leukocyte adhesion and migration

Aug. 12, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....
Shanghai Yingli Pharmaceutical identifies new KRAS mutant inhibitors
BioWorld Science
Shanghai Yingli Pharmaceutical Co. Ltd. has discovered hydrazine-structured compounds as inhibitors of GTPase KRAS and its mutants. They are reported to be useful...